About Cryoniss
Cryoniss is a Healthcare company based in Macclesfield (United Kingdom) founded in 2018 by Phil Hargreaves and Sonia Houghton, and was acquired by Biofortuna in May 2024. It operates as a provider of biobanking services for life sciences industries. Cryoniss has raised $683.06 thousand across 1 funding round from investors including Maven Capital Partners and Biofortuna. The company has 9 employees. Its chief executive is Sonia Houghton. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Research Services and Biorepository. Its legal entity is CRYONISS LTD. Its competitors include GenVault Corporation, iSpecimen, PrecisionMed, AminoChain and ViaCell and 2 more; 5 of its 7 listed competitors have raised funding.
Company details
Cryoniss was established in 2018 in Macclesfield, United Kingdom, as a provider of biobanking services within the life sciences sector. Human biological samples are stored in vapor-phase liquid nitrogen or at ambient temperatures. Clinical samples from various trial phases are accommodated, along with bioreagents such as glycerol stocks, DNA, frozen cultures, and antibodies maintained at ambient conditions. Operations focus on secure preservation for research and development needs.
- Headquarters Macclesfield, United Kingdom
- Employees 9
- Founders Phil Hargreaves, Sonia Houghton
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website cryoniss.com
- Social LinkedIn X
- Acquired by Biofortuna (May 2024)
- Legal Name Cryoniss Ltd.
- Date of Incorporation 06 Mar, 2018
- Jurisdiction MACCLESFIELD, ENGLAND
- Total Equity Funding$683.06K (USD)
in 1 rounds
- Latest Funding Round$683.06K (USD), Seed
Jan 2022
- InvestorsMaven Capital Partners
& 1 more
- Employee Count9
- Acquired byBiofortuna
(May 2024)
Funding Insights of Cryoniss
Cryoniss has successfully raised a total of $683.06K through 1 strategic funding round. The most recent funding activity was a Seed round of $683.06 thousand completed in January 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $683,055
- Total Rounds 1
- Last Round Seed — $683,055
- First Round $683,055
(Jan 2022)
- Investors Count 1
All 1 funding rounds of Cryoniss with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan 2022 | $683,055 | Seed | – | Maven Capital Partners | – |
2 investors in total: 2 institutional.
Investors in Cryoniss
Cryoniss has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Maven Capital Partners and Biofortuna.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Multiple sectors are targeted for private equity investments. | 2005 | mavencp.com | Birmingham, United Kingdom | |
Provider of manufacturing services for immunoassays, molecular diagnostics, and regulatory services | 2008 | biofortuna.com | Birkenhead, United Kingdom |
Investor details for Cryoniss
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Cryoniss
3 people are tracked at Cryoniss (2 in leadership, 1 in team); the tracked headcount is 9.
| Name | Role | Group |
|---|---|---|
Phil Hargreaves | Co-Founder & COO | Leadership |
Sonia Houghton | Co-Founder & CEO | Leadership |
Philip Hargreaves | Operations Manager – Controlled Environment Storage | Team |
Complete people profiles for Cryoniss
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Cryoniss
3 dated milestones of Cryoniss across 6 years, from founding to its latest funding, stage changes and deals.
- Founded Cryoniss is founded.
- Funding First funding round of $683K.
- Exit Acquired by Biofortuna.
Competitors of Cryoniss
Cryoniss has 7 listed competitors in our database, 5 of them funded. They include GenVault Corporation, iSpecimen, PrecisionMed, AminoChain and ViaCell, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| genvault.com | 2000 | Carlsbad, United States | $47.8M | – | Biosamples are stabilized, transported, stored, and retrieved by GenVault. | |
| ispecimen.com | 2009 | Lexington, United States | $11.86M | 75 | Provider of a biorepository of human clinical specimens | |
| precisionmed.com | 1996 | San Diego, United States | – | – | Human biological materials for research are supplied via a biorepository. | |
| aminochain.io | 2022 | New York, United States | $7.07M | – | A blockchain-based platform for tokenizing and incentivizing stem cell donations | |
| viacellinc.com | 1994 | Cambridge, United States | $63M | – | Provider of services for collecting and preserving umbilical cord blood stem cells | |
| indivumed.com | 2002 | Hamburg, Germany | – | 178 | Biospecimens are collected, preserved, and analyzed for oncology services. | |
| biostorage.com | 2002 | Indianapolis, United States | $8.77M | – | Provides bio repository services |
Detailed competitors of Cryoniss
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Cryoniss
The website of Cryoniss (cryoniss.com) receives about 1.3K visits a month.
- Monthly visits1.3K
▼ 20.7% vs previous month
Top companies in Life Sciences Platforms & Tools
10 companies that operate in the same segment as Cryoniss (Life Sciences Platforms & Tools), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | – | – | |
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | – | 1,111 | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.34 B | USD 301.49 M | 1,372 | |
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Biological reagents and antibodies are developed for life science research. | 1998 | Cambridge, Cambridgeshire, United Kingdom | USD 78.8 M | – | – | |
Electron microscopy services and microanalysis instruments are provided. | 1956 | Waltham, Massachusetts, United States | – | USD 44.56 B | 125,000 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
A platform for sharing and accessing academic research papers is provided. | 2008 | San Francisco, California, United States | USD 58.4 M | – | – | |
Developer of molecular diagnostic testing solutions | 1996 | Sunnyvale, California, United States | USD 19.1 M | USD 54.88 M | 208 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Cryoniss
Complete news archive for Cryoniss
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Cryoniss
Cryoniss was founded in 2018 and raised its 1st funding round 4 years after it was founded.
Cryoniss is headquartered in Macclesfield, United Kingdom. It is registered at Macclesfield, Cheshire, United Kingdom.
Sonia Houghton is the current CEO of Cryoniss. They have also founded this company.
Cryoniss is a funded company, having raised a total of $683.06K across 1 funding round to date. The company's 1st funding round was a Seed of $683.06K, raised on Jan 2022.
Cryoniss has 9 employees.
Cryoniss was established in 2018 in Macclesfield, United Kingdom, as a provider of biobanking services within the life sciences sector. Human biological samples are stored in vapor-phase liquid nitrogen or at ambient temperatures. Clinical samples from various trial phases are accommodated, along with bioreagents such as glycerol stocks, DNA, frozen cultures, and antibodies maintained at ambient conditions. Operations focus on secure preservation for research and development needs.
Cryoniss's top competitors include iSpecimen, AminoChain and GenVault Corporation.
Cryoniss has 2 investors. Key investors include Maven Capital Partners, and Biofortuna.
Cryoniss operates through Cryoniss Ltd..
Yes. Cryoniss was acquired by Biofortuna in May 2024.